Plain-English translation of NCT06764524 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to study tiny particles called extracellular vesicles that float in the blood of people with hairy cell leukemia. These particles may hold clues about how the disease works and how it affects the body. By comparing blood samples from patients with hairy cell leukemia to healthy volunteers, scientists hope to discover new ways to diagnose and monitor this rare blood cancer.
Very little is known about these tiny particles in hairy cell leukemia patients and what role they play in the disease. Understanding their makeup could reveal important biomarkers—signs that doctors could use to better manage patient care and potentially improve treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be asked to donate a blood sample that researchers will use to isolate and analyze the tiny particles in your blood. The study compares samples from patients with hairy cell leukemia to samples from healthy volunteers to identify disease-related patterns. You may also be asked to provide basic health information as part of the research process.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy
Enrollment target
~50 participants
Started
December 2024
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lucia Catani, PhD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.